Literature DB >> 8586639

Preparation of recombinant argininosuccinate synthetase and argininosuccinate lyase: expression of the enzymes in rat tissues.

Y Yu1, K Terada, A Nagasaki, M Takiguchi, M Mori.   

Abstract

Nitric oxide (NO) is synthesized from arginine by nitric oxide synthase, generating citrulline as another product, which can be recycled to arginine by argininosuccinate synthetase and argininosuccinate lyase. Rat argininosuccinate synthetase was expressed in Escherichia coli as a fusion protein with maltose binding protein, cleaved from binding protein, and purified. The purified synthetase had no enzyme activity. Rat argininosuccinate lyase was expressed in E. coli using pET-3a as a vector, and purified. The purified enzyme had a specific enzyme activity of arginine formation of 2.6 mumol/min/mg protein at 37 degrees C, the value being somewhat lower than those of the enzyme purified from various tissues. Antibodies against these enzymes were produced in rabbits. Immunoblot analyses showed that the two enzymes are most abundant in the liver, followed by kidney and testis. Smaller amounts of the enzyme proteins were present in other tissues. RNA blot analysis showed that the argininosuccinate synthetase mRNA was most abundant in the liver and kidney, followed by testis and other tissues. On the other hand, argininosuccinate lyase mRNA was most abundant in the testis, followed by kidney and liver, and by other tissues. These results show that argininosuccinate synthetase and argininosuccinate lyase are expressed both tissue-specifically and ubiquitously, and that practically all tissues have activities to convert citrulline to arginine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586639     DOI: 10.1093/oxfordjournals.jbchem.a124826

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Authors:  Gin-Fu Chen; Laszlo Wagner; Jennifer M Sasser; Sergey Zharikov; Natasha C Moningka; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2010-05-19       Impact factor: 5.992

Review 2.  Transcriptional regulation of genes for ornithine cycle enzymes.

Authors:  M Takiguchi; M Mori
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

3.  The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge.

Authors:  Yang Yuan; Mahmoud A Mohammad; Ancizar Betancourt; Inka C Didelija; Chandrasekar Yallampalli; Juan C Marini
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

4.  In vivo renal arginine release is impaired throughout development of chronic kidney disease.

Authors:  Gin-Fu Chen; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

5.  Induction of molecular chaperones in carbon tetrachloride-treated rat liver: implications in protection against liver damage.

Authors:  Kwang-Jong Lee; Kazutoyo Terada; Seiichi Oyadomari; Yukihiro Inomata; Masataka Mori; Tomomi Gotoh
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

6.  Regulation of the urea cycle enzyme genes in nitric oxide synthesis.

Authors:  M Mori; T Gotoh; A Nagasaki; M Takiguchi; T Sonoki
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

7.  Extrarenal citrulline disposal in mice with impaired renal function.

Authors:  Juan C Marini; Inka C Didelija; Marta L Fiorotto
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-23

8.  High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells.

Authors:  S Todoroki; S Goto; Y Urata; K Komatsu; K Sumikawa; T Ogura; I Matsuda; T Kondo
Journal:  Mol Med       Date:  1998-08       Impact factor: 6.354

9.  Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53.

Authors:  Takafumi Miyamoto; Paulisally Hau Yi Lo; Naomi Saichi; Koji Ueda; Makoto Hirata; Chizu Tanikawa; Koichi Matsuda
Journal:  Sci Adv       Date:  2017-05-19       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.